Abstract 395P
Background
Google Trends, a free web-based tracking system of Google search volumes, can be used to monitor online interest in various health conditions, including lung cancer. This is particularly useful in the Philippines, the country named as the world's number one internet user in 2018. Understanding the pattern of information-seeking behavior of Filipinos with regards to lung cancer is crucial because it may inform public policy and potentially make lung cancer awareness campaigns more directed and effective in the population-based setting. Here we described patterns in online search behaviors related to lung cancer using Google Trends data on Google web and YouTube searches in the Philippines for the past ten years.
Methods
Relative search volumes on the term “lung cancer” from 2009 to 2019 were extracted from Google Trends. Both Google web search and YouTube search data were downloaded. The data were saved in a comma-separated values file then imported to Microsoft Excel where a graph was plotted and a polynomial trendline (second order) was added to estimate search trends over a time period. Regions and cities in the Philippines where the term “lung cancer” was most popular were identified. Related topics and queries were also enumerated.
Results
Trends in Google web search showed a steady interest in lung cancer for both Google web search and YouTube searches from 2009 to 2019, with peaks in 2014. No spikes were observed in August, the Philippines’ Lung Cancer Awareness month. Online search behaviour for lung cancer was greatest in Metro Manila and areas in Northern Philippines. Top related and rising topics and queries in lung cancer, both on Google web search and YouTube, were related to etiology, symptoms, and management of lung cancer.
Conclusions
Filipinos had a steady interest in lung cancer, as shown by Google Trends data for both Google web search and YouTube searches from 2009 to 2019. Cancer diagnoses of Filipino personalities in 2014 may have led to peaks in online interest. Filipinos were also interested to learn about etiology, symptoms, and management of lung cancer. These data may be used to leverage online interest to optimize lung cancer awareness campaigns in the Philippines.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
490P - Outcomes of sequential epidermal growth factor receptor tyrosine (EGFR) tyrosine kinase inhibitor (TKI) therapy in patients with advanced non-small cell lung carcinoma (NSCLC)- a real-world institutional experience
Presenter: Yvonne Ang
Session: Poster display session
Resources:
Abstract
498P - An observational retrospective study to evaluate the incidence of acquired EGFR T790M resistance in NSCLC patients with EGFR mutation following progression after at least one prior EGFR TKI treatment in Taiwan: ARISE study
Presenter: Shang-gin Wu
Session: Poster display session
Resources:
Abstract
501P - Clinical characteristics and efficacy in non-small cell lung cancer patients with EGFR exon 20 insertion and EGFR amplification
Presenter: Xin Gao
Session: Poster display session
Resources:
Abstract
502P - Epidermal growth factor receptor tyrosine kinase inhibitor treatment response in advanced non-small cell lung cancer with uncommon mutations: A multicenter observational study
Presenter: Masaki Kanazu
Session: Poster display session
Resources:
Abstract
482P - Interim analysis from a phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC
Presenter: Filippo De Marinis
Session: Poster display session
Resources:
Abstract
483P - A phase IIIb, open-label study of afatinib in EGFR TKI-naïve patients with EGFR mutation-positive NSCLC: A biomarker analysis
Presenter: Rafael Rosell
Session: Poster display session
Resources:
Abstract
484P - Activity of afatinib in patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC and baseline brain metastases: Pooled analysis of three large phase IIIb trials
Presenter: Maya Gottfried
Session: Poster display session
Resources:
Abstract
491P - Clinical outcomes of leptomeningeal metastases in EGFR-mutant lung adenocarcinoma
Presenter: Chia-I Shen
Session: Poster display session
Resources:
Abstract
510P - Paclitaxel as continuation maintenance therapy in patients with advanced non-small cell lung cancer
Presenter: Suzy Gohar
Session: Poster display session
Resources:
Abstract
496P - Higher osimertinib introduction rate achieved by multiple repeated re-biopsy after acquired resistance to first/second generation EGFR-TKIs
Presenter: Taira Ninomaru
Session: Poster display session
Resources:
Abstract